CUE
Price
$1.71
Change
-$0.03 (-1.72%)
Updated
May 17, 6:59 PM EST
106 days until earnings call
PRME
Price
$7.08
Change
+$0.04 (+0.57%)
Updated
May 17, 6:59 PM EST
78 days until earnings call
Ad is loading...

CUE vs PRME

Header iconCUE vs PRME Comparison
Open Charts CUE vs PRMEBanner chart's image
Cue Biopharma
Price$1.71
Change-$0.03 (-1.72%)
Volume$71.83K
CapitalizationN/A
Prime Medicine
Price$7.08
Change+$0.04 (+0.57%)
Volume$340.27K
CapitalizationN/A
View a ticker or compare two or three
CUE vs PRME Comparison Chart

Loading...

CUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CUE vs. PRME commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a StrongSell and PRME is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (CUE: $1.71 vs. PRME: $7.08)
Brand notoriety: CUE and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 39% vs. PRME: 81%
Market capitalization -- CUE: $83.18M vs. PRME: $849.82M
CUE [@Biotechnology] is valued at $83.18M. PRME’s [@Biotechnology] market capitalization is $849.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, CUE is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 3 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • CUE’s TA Score: 3 bullish, 7 bearish.
  • PRME’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRME is a better buy in the short-term than CUE.

Price Growth

CUE (@Biotechnology) experienced а -1.72% price change this week, while PRME (@Biotechnology) price change was +26.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

CUE is expected to report earnings on Sep 02, 2024.

PRME is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CUE with price predictions.
OPEN
A.I.dvisor published
a Summary for PRME with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PRME($850M) has a higher market cap than CUE($83.2M). PRME YTD gains are higher at: -20.090 vs. CUE (-35.227).
CUEPRMECUE / PRME
Capitalization83.2M850M10%
EBITDAN/AN/A-
Gain YTD-35.227-20.090175%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CUEPRME
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 14 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
CUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBBXF0.100.01
+10.71%
Brixton Metals Corp.
JMPLY46.930.36
+0.78%
Johnson Matthey plc
SVNDY12.95-0.01
-0.08%
Seven & I Holdings Co., Ltd.
BOUYY7.68-0.05
-0.65%
Bouygues SA
PET1.93-0.10
-4.93%
Wag! Group Co

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with BEAM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+0.57%
BEAM - PRME
64%
Loosely correlated
+3.49%
NTLA - PRME
64%
Loosely correlated
+0.19%
XNCR - PRME
53%
Loosely correlated
+2.54%
RLAY - PRME
53%
Loosely correlated
+2.00%
EDIT - PRME
50%
Loosely correlated
-4.58%
More